Patrick G. Enright - 11 Dec 2025 Form 4 Insider Report for Vera Therapeutics, Inc. (VERA)

Reporting relationship: Director
Issuer ticker: VERA
Reported as of: 11 Dec 2025
Net transaction value: +$249,985
SEC form: 4
Accepted by SEC: 15 Dec 2025, 20:07:34 UTC
Prior SEC filing: 14 Oct 2025
Next SEC filing: 05 Feb 2026
Source filing: View source filing
Reporting owner signature: /s/ Cristiana Blauth Oliveira, as attorney-in-fact for Patrick G. Enright

Key filing fact

Patrick G. Enright filed Form 4 for Vera Therapeutics, Inc. (VERA) on 15 Dec 2025.

Key facts

This page summarizes Patrick G. Enright's Form 4 filing for Vera Therapeutics, Inc. (VERA).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 15 Dec 2025, 20:07.

Change

Previous filing in this sequence was filed on 14 Oct 2025.
Current net transaction value: +$249,985.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001253886 Primary reporting owner

ENRIGHT PATRICK G

Relationship: Director
Address: C/O LONGITUDE CAPITAL MANAGEMENT, 2740 SAND HILL ROAD, 2ND FLOOR, MENLO PARK
Signature: /s/ Cristiana Blauth Oliveira, as attorney-in-fact for Patrick G. Enright
Signature date: 15 Dec 2025

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

VERA transaction

Class A Common Stock

Purchase

Transaction value: $249,985
Shares: +5,882
Change %
Price: $42.50
Shares after: 5,882
Date: 11 Dec 2025
Ownership: Direct

VERA holding

Class A Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 1,797,619
Date: 11 Dec 2025
Ownership: See footnote
Footnotes: F1

VERA holding

Class A Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 3,596,593
Date: 11 Dec 2025
Ownership: See footnote
Footnotes: F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

These shares are held by Longitude Prime Fund, L.P. ("LPF"). Longitude Prime Partners, LLC ("LPP") is the general partner of LPF and may be deemed to have voting and dispositive power over the securities held by LPF. The Reporting Person and Juliet Tammenoms Bakker are the managing members of LPP and may be deemed to share voting and dispositive power over the shares held by LPF. Each of LPP, the Reporting Person and Ms. Tammenoms Bakker disclaims beneficial ownership of such shares and this report shall not be deemed an admission that any of them is the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of their respective pecuniary interests therein.

Footnote F2

These shares are held by Longitude Venture Partners IV, L.P ("LVPIV"). Longitude Capital Partners IV, LLC ("LCPIV") is the general partner of LVPIV and may be deemed to have voting and dispositive power over the shares held by LVPIV. The Reporting Person and Ms. Tammenoms Bakker are managing members of LCPIV and may be deemed to share voting and dispositive power with respect to the shares held by LVPIV. Each of LCPIV, the Reporting Person and Ms. Tammenoms Bakker disclaims beneficial ownership of such shares and this report shall not be deemed an admission that any of them is the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of their respective pecuniary interests therein.